NuVasive (NUVA) Misses Q3 EPS by 23c; Lowers Outlook

Go back to NuVasive (NUVA) Misses Q3 EPS by 23c; Lowers Outlook

NuVasive (NUVA) PT Lowered to $75 at Truist Securities

November 10, 2021 6:48 AM EST

Truist Securities analyst Samuel Brodovsky lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $80.00) while maintaining a Buy rating.

The analyst commented, "NUVA reported 3Q results with sales of $271M down ~8% sequentially, while adj. EPS came in at $0.32. Updated... More

NuVasive (NUVA) PT Lowered to $64 at Needham & Company

November 10, 2021 6:25 AM EST

Needham & Company analyst Mike Matson lowered the price target on NuVasive (NASDAQ: NUVA) to $64.00 (from $73.00) while maintaining a Buy rating.

The analyst commented, "NUVA's 3Q21 revenue was in line with its preannouncement while its EPS missed consensus. Management lowered 2021 revenue guidance... More